معرفی
Audra Stinchcomb is a Professor of Pharmaceutical Sciences at the University of Maryland School of Pharmacy, where she leads innovative research in transdermal and topical drug delivery, particularly focusing on microneedle-enhanced systems and prodrug development.
- University: University of Maryland
- School: School of Pharmacy
- Department: Department of Pharmaceutical Sciences
- Email: astinchc@rx.umaryland.edu
Dr. Stinchcomb’s research spans pharmaceutics, pharmacokinetics, complex drug product development, and regulatory science, with a strong translational focus. She has pioneered work in abuse-deterrent opioid formulations, cannabinoid delivery (especially THC and CBD prodrugs), and methods to prolong micropore lifetime in microneedle applications. Her work bridges academic innovation and industry application through public-private partnerships.
The recent publications and patents reflect a consistent trend in transdermal delivery optimization, particularly for cannabinoids and opioids, utilizing prodrug strategies and microneedle technologies to enhance efficacy, safety, and patient compliance. These innovations are aimed at treating chronic pain, neurological disorders, and inflammatory conditions.
Scientific Honors:
- Fellow, American Association of Pharmaceutical Scientists (FAAPS)
- Fellow, American Institute for Medical and Biological Engineering (FAIMBE)
Dr. Stinchcomb is also a serial entrepreneur and active in venture capital, contributing to StageNext VC, which supports women-led biotech startups. She mentors through her research program and participates in professional education initiatives, such as FDA IVPT guidance implementation workshops. Her lab is at the forefront of developing novel drug delivery platforms with significant commercial and public health impact.
حوزههای پژوهشی
